French insurtech Alan has raised another €480M at a €5.5bn valuation — its second major round in a matter of months.
Dutch investor Prosus led the deal, which values the Paris-based health insurer at €5.5bn ($6.3bn). Alan raised €480m ($550m) total in this round. The company is positioning AI-driven prevention — think tools that flag health risks before claims happen — as the core differentiator from legacy insurers. The rapid fundraising cadence suggests investors believe that thesis enough to keep writing checks.
Health insurance is a notoriously sticky, low-margin business where incumbents win on scale and regulatory relationships. Alan's bet is that AI can shift the product from reactive payout machine to proactive health platform — which, if it works, could justify a premium price and lower claims costs at the same time. That is a compelling story; it is also exactly what every health tech startup says.
At €5.5bn, Alan is priced for a future where that story proves out — not the one where it turns out prevention is harder to monetize than a pitch deck suggests.